211 related articles for article (PubMed ID: 8688159)
1. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen.
Hecht SS
Crit Rev Toxicol; 1996; 26(2):163-81. PubMed ID: 8688159
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines.
Hecht SS; Carmella SG; Foiles PG; Murphy SE
Cancer Res; 1994 Apr; 54(7 Suppl):1912s-1917s. PubMed ID: 8137311
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes.
Smith GB; Bend JR; Bedard LL; Reid KR; Petsikas D; Massey TE
Drug Metab Dispos; 2003 Sep; 31(9):1134-41. PubMed ID: 12920169
[TBL] [Abstract][Full Text] [Related]
4. Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA.
Cloutier JF; Drouin R; Weinfeld M; O'Connor TR; Castonguay A
J Mol Biol; 2001 Oct; 313(3):539-57. PubMed ID: 11676538
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA methylation in the activation of proto-oncogenes and the induction of pulmonary neoplasia by nitrosamines.
Belinsky SA; Devereux TR; Anderson MW
Mutat Res; 1990; 233(1-2):105-16. PubMed ID: 2233792
[TBL] [Abstract][Full Text] [Related]
6. Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans.
Hecht SS; Carmella SG; Foiles PG; Murphy SE; Peterson LA
Environ Health Perspect; 1993 Mar; 99():57-63. PubMed ID: 8319660
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse.
Li L; Megaraj V; Wei Y; Ding X
Carcinogenesis; 2014 Nov; 35(11):2584-91. PubMed ID: 25173884
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate.
Smith TJ; Guo Z; Li C; Ning SM; Thomas PE; Yang CS
Cancer Res; 1993 Jul; 53(14):3276-82. PubMed ID: 8324738
[TBL] [Abstract][Full Text] [Related]
10. DNA adduct formation from tobacco-specific N-nitrosamines.
Hecht SS
Mutat Res; 1999 Mar; 424(1-2):127-42. PubMed ID: 10064856
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Sturla SJ; Scott J; Lao Y; Hecht SS; Villalta PW
Chem Res Toxicol; 2005 Jun; 18(6):1048-55. PubMed ID: 15962940
[TBL] [Abstract][Full Text] [Related]
12. Stable isotope labeling-mass spectrometry analysis of methyl- and pyridyloxobutyl-guanine adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in p53-derived DNA sequences.
Rajesh M; Wang G; Jones R; Tretyakova N
Biochemistry; 2005 Feb; 44(6):2197-207. PubMed ID: 15697245
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
Chiang HC; Wang CY; Lee HL; Tsou TC
Toxicol Appl Pharmacol; 2011 Jun; 253(2):145-52. PubMed ID: 21473878
[TBL] [Abstract][Full Text] [Related]
14. Effect of tobacco smoke condensate on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by adult and fetal hamster microsomes.
Jorquera R; Castonguay A; Schuller HM
Drug Metab Dispos; 1993; 21(2):318-24. PubMed ID: 8097703
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system.
Guo Z; Smith TJ; Ishizaki H; Yang CS
Carcinogenesis; 1991 Dec; 12(12):2277-82. PubMed ID: 1747927
[TBL] [Abstract][Full Text] [Related]
16. K-ras gene sequence effects on the formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-DNA adducts.
Ziegel R; Shallop A; Jones R; Tretyakova N
Chem Res Toxicol; 2003 Apr; 16(4):541-50. PubMed ID: 12703972
[TBL] [Abstract][Full Text] [Related]
17. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.
Megaraj V; Zhou X; Xie F; Liu Z; Yang W; Ding X
Carcinogenesis; 2014 Jan; 35(1):131-7. PubMed ID: 23917075
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of lipoxygenase in bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung.
Bedard LL; Smith GB; Reid KR; Petsikas D; Massey TE
Chem Res Toxicol; 2002 Oct; 15(10):1267-73. PubMed ID: 12387624
[TBL] [Abstract][Full Text] [Related]
19. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
Finckh C; Atalla A; Nagel G; Stinner B; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
[TBL] [Abstract][Full Text] [Related]
20. Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.
Zhou X; D'Agostino J; Xie F; Ding X
J Pharmacol Exp Ther; 2012 Apr; 341(1):233-41. PubMed ID: 22262919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
